(B) TFR2 mRNA expression is borderline increased in sorted bone marrow ProE from MDS relative to WT mice and remains significantly elevated in DFP-treated MDS relative to WT mice (n=15–18 mice/group). This evidence concerns the gene TFR2 and myelodysplastic syndrome.